Previous 10 | Next 10 |
Maravai LifeSciences (MRVI) has added ~3.2% in the pre-market. Yesterday, after the close, the company announced the outcome of its annual meeting of shareholders for 2021 held on Wednesday.The highlight of the disclosure was the election of four currently serving director...
The following slide deck was published by Maravai LifeSciences Holdings, Inc. in conjunction with this event. For further details see: Maravai LifeSciences Holdings (MRVI) Investor Presentation - Slideshow
Image source: The Motley Fool. Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Q1 2021 Earnings Call May 10, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2021 Earn...
The following slide deck was published by Maravai LifeSciences Holdings, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Maravai LifeSciences Holdings, Inc. 2021 Q1 - Results - Earnings Call Presentation
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2021 Earnings Conference Call May 10, 2021 17:00 ET Company Participants Deb Hart - Investor Relations Carl Hull - Chairman and Chief Executive Officer Kevin Herde - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanle...
Maravai LifeSciences Holdings (MRVI): Q1 Non-GAAP EPS of $0.26 beats by $0.05; GAAP EPS of $0.24 beats by $0.05.Revenue of $148.2M (+190.7% Y/Y) beats by $8.74M.Updated 2021 revenue guidance of $680.0 million to $720.0 million, representing full year growth of 139.4% to 153.5%.Adjusted EBITDA...
SAN DIEGO, May 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai)(NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2021. Highl...
[[ACM]], [[AEE]], [[AFRM]], [[BHF]], [[BRKS]], [[CNNE]], [[CPSI]], [[CSTL]], [[DDD]], [[EGHT]], [[ELY]], [[EVBG]], [[FGEN]], [[FOE]], [[G]], [[HALO]], [[HHC]], [[HLIO]], [[IFF]], [[INO]], [[IPAR]], [[JCOM]], [[MBI]], [[MESA]], [[MGNI]], [[MODN]], [[MRVI]], [[NCMI]], [[NHI]], [[NLOK]], [[NLS]]...
SAN DIEGO, May 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of May. ...
SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, announced today the addition of three independent directors to it...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
2024-07-25 20:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...